GlassScriptPhysician profile
Ted A Matthews
NPI 1669460333
$7,084.35
in general payments reported to CMS, 2019-2025
8 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $229 · 2021: $396 · 2022: $331 · 2023: $424 · 2024: $5,329 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,870 · Food and Beverage: $1,647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,869.50 |
| Food and Beverage | $1,647.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,949.26 | 2024 | |
| Ethicon US, LLC | $1,136.65 | 2019-2025 | Stratafix, Vistaseal, Evarrest |
| Innovation Technologies INC | $789.59 | 2019-2024 | Irrisept |
| Sanara Medtech INC. | $87.09 | 2023 | Celleraterx |
| Cumberland Pharmaceuticals, INC. | $70.73 | 2021-2025 | Caldolor |
| Stryker Corporation | $20.20 | 2021 | |
| Becton, Dickinson and Company | $17.05 | 2025 | Phasix Mesh |
| Acelrx Pharmaceuticals, INC. | $13.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.